Riskpilot← Back to searchSign inGet full accessNeurosonic Sverige AB
ABActiveOrg 5593164964Skönviksvägen 247Wholesale of pharmaceutical and medical goods · NACE 4646Est. 20211 employees
Revenue 2024
SEK 303K
+209% vs 2023
EBITDA margin
-14.2%
+96% vs 2023
Equity ratio
37.9%
Financial strength
Net profit 2024
SEK -42K
+96% vs 2023
| Revenue | SEK 303K | +209% |
| EBITDA | SEK -43K | +96% |
| Net profit | SEK -42K | +96% |
| Total assets | SEK 253K | +37% |
| Equity | SEK 96K | -30% |
| Employees | 1 | — |
Legal name
Neurosonic Sverige AB
Org number
5593164964
Legal form
Aktiebolag
NACE code
4646 · Wholesale of pharmaceutical and medical goods
Founded
10 maj 2021
Share capital
SEK 25 000
Employees
1 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen Firman tecknas var för sig av ledamoten suppleanten
Company purpose
Bolaget ska bedriva partihandel med diagnostiska instrument och medicinsk och ortopedisk utrustning.
Address
Skönviksvägen 247
Email
info@neurosonic.se
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|
| Revenue | 70 | 266 | 98 | 303 |
| Staff expenses | — | — | — | — |
| EBITDA | −1 079 | −927 | −1 129 | −43 |
| Depreciation & amort. | −0 | −0 | −0 | −0 |
| EBIT | −1 079 | −927 | −1 129 | −43 |
| Net financials | — | — | — | 1 |
| Profit before tax | −1 079 | −927 | −1 129 | −42 |
| Tax | −0 | −0 | −0 | −0 |
| Net profit | −1 079 | −927 | −1 129 | −42 |
| Item | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|
| Total assets | 333 | 197 | 185 | 253 |
| Equity | 191 | 93 | 138 | 96 |
| Long-term debt | 0 | 0 | 0 | 0 |
| Short-term debt | 142 | 103 | 47 | 156 |
| Total debt | 142 | 103 | 47 | 156 |
EBITDA margin
-14.2%
This company
15.8%
Market median
-190% vs market
20212024
Equity ratio
37.9%
This company
38.2%
Market median
+1% vs market
20212024
Return on equity
-43.8%
This company
18.4%
Market median
-338% vs market
20212024
Net profit margin
-13.9%
This company
8.1%
Market median
-272% vs market
20212024
Asset turnover
1.20×
This company
1.12×
Market median
+7% vs market
20212024
Debt / equity
1.64×
This company
0.62×
Market median
-165% vs market
20212024
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-05-01 – 2021-12-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
JE Authorized Recipient of Service | Authorized Recipient of Service | 2024 |
| Former (1) | ||
EJ Authorized Recipient of Service | Authorized Recipient of Service | 2021 – 2024 |
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Deputy Board Member | 2021 | |
| Board of Directors | 2021 | |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Company | 100% | 100% | 2025 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
OY NEUROSONIC FINLAND LTD
Neurosonic Sverige AB (this company)Board members of Neurosonic Sverige AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Julia Elise Vernersson | Authorized Recipient of Service | 0 companies |
| Erik Jesper Jakob Skarin | Authorized Recipient of Service | 0 companies |
| Juha Valdemar Suoniemi | Deputy Board Member | 0 companies |
| Jonne Kalevi Soininen | Board of Directors | 0 companies |